SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-18-017854
Filing Date
2018-12-26
Accepted
2018-12-26 16:06:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs32018_delmarpharma.htm S-3 240128
2 LEGAL OPINION OF FENNEMORE CRAIG, P.C.** fs32018ex5-1_delmarpharma.htm EX-5.1 18367
3 CONSENT OF ERNST & YOUNG LLP** fs32018ex23-1_delmarpharma.htm EX-23.1 3270
4 GRAPHIC img_001.jpg GRAPHIC 24100
  Complete submission text file 0001213900-18-017854.txt   296150
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-229020 | Film No.: 181252758
SIC: 2834 Pharmaceutical Preparations